The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nikolaeva M.G.

Obstetrics and Gynecology Department with the course of Supplementary Vocational Education in FSBEI of Higher Education «Altai State Medical University» Barnaul, Russia

Serdiuk G.V.

Hematology Research Center, Ministry of Health of Russia, Altai Branch, Barnaul;
Altai State Medical University, Ministry of Health of Russia, Barnaul

Gorbacheva T.I.

Altay State Medical University, Barnaul, Russia, 656038

Yavorskaya S.D.

Department of Obstetrics and Gynecology with Course of Additional Professional Education, Altai State Medical University, Ministry of Health of Russia, Barnaul, Russia

Momot A.P.

Altai Branch of the FSBI «National Research Center for Hematology», Barnaul, Russia

Relationship between preeclampsia and SERPINE1 (PAI-1-675 G4/G5) gene polymorphism. Systematic review. A metaanalysis

Authors:

Nikolaeva M.G., Serdiuk G.V., Gorbacheva T.I., Yavorskaya S.D., Momot A.P.

More about the authors

Journal: Russian Journal of Human Reproduction. 2016;22(4): 115‑122

Read: 3615 times


To cite this article:

Nikolaeva MG, Serdiuk GV, Gorbacheva TI, Yavorskaya SD, Momot AP. Relationship between preeclampsia and SERPINE1 (PAI-1-675 G4/G5) gene polymorphism. Systematic review. A metaanalysis. Russian Journal of Human Reproduction. 2016;22(4):115‑122. (In Russ.)
https://doi.org/10.17116/repro2016224115-122

Recommended articles:
On mole­cular gene­tic predictors of preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):26-34
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10

References:

  1. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-474.
  2. Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy. 2012;2012:105918 *Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366228/ (Accessed 1 April 2016)
  3. Sidorova IS, Nikitina NA. The modern view on the problem of pre-eclampsia: the arguments and facts. Akusherstvo i ginekologija. 2012;5:10-16. (In Russ.).
  4. Tranquilli AL, Landi B, Giannubilo SR, Sibai B. Preeclampsia: No longer solely a pregnancy disease. Pregnancy Hypertens. 2012;2:350-357.
  5. Hodzhaeva ZS, Holin AM, Vihljaeva EM. Early and late preeclampsia: patobiology paradigms and clinical practice. Akusherstvo i ginekologija. 2013;10:4-11. (In Russ.).
  6. Sidorova IS, Milovanov AP, Nikitina NA, Bardachova AV, Rzaeva AA. Severe preeclampsia and eclampsia: critical conditions for the mother and fetus. Akusherstvo i ginekologija. 2013;12:34-40. (In Russ.).
  7. Ghulmiyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56-59.
  8. Bajbarina EN, Filippov OS, Guseva EV. Modernization of maternity and child care service in the Russian Federation: results and prospects. Akusherstvo i ginekologija. 2013;12:4-9. (In Russ.).
  9. Sidorova IS, Kurcer MA, Nikitina NA, Rzaeva AA. Role of the fetus in the development of preeclampsia. Akusherstvo i ginekologija. 2012;5:23-28. (In Russ.).
  10. Hodzhaeva ZS, Kogan EA, Safonova AD, Akat'ev AS, Muminova KT, Fajzullin AL. The placental bed and preeclampsia. Akusherstvo i ginekologija. 2013;12:10-15 (In Russ.).
  11. Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy. 2012;2012:374047 *Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235807/ (Accessed 1 April 2016).
  12. LaMarca B. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012;64(4):309-320.
  13. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33-46.
  14. Vodneva DN, Shmakov RG, Shhegolev AI. Роль маркеров инвазии трофобласта в развитии преэклампсии и опухолевого роста. Akusherstvo i ginekologija. 2013;11:9-12. (In Russ.).
  15. Dikur ON, Kopylov FYu. Clinical significance of endothelial dysfunction in pregnancy as a component of comprehensive evaluation of pre-eclampsia risk. Arhiv akusherstva i ginekologii im. V.F. Snegireva. 2014;(1)2:7-13. (In Russ.).
  16. Van De Craen B, Declerck PJ, Gils A. The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res. 2012;(130)4:576-585.
  17. Litvinov RI. Molecular mechanisms and clinical significance of fibrinolysis. Kazanskij medicinskij zhurnal. 2013;(94)5:711-718. (In Russ.).
  18. Robb AO, Mills NL, Din JN, Cameron S, Ludlam CA, Newby DE, et al. Acute endothelial tissue plasminogen activator release in pregnancy. J Thromb Haemost. 2009;7(1):138-142.
  19. Klepikova AA, Zolotyh OS, Evseeva ZP, Azarova TE, Kazanceva TA, Sagamonova KYu. Thrombophilia and pregnancy outcomes. Kazanskij medicinskij zhurnal. 2011;(92)6:846-850. (In Russ.).
  20. Kirjushhenkov PA, Hodzhaeva ZS, Tetruashvili NK, Donnikov AE, Belousov DM, Andamova EV, et al. Significance of plasminogen activator inhibitor type 1 gene (SERPINE1: 5G>4G) polymorphism in chorionic detachment and placental abruption in early pregnancy. Akusherstvo i ginekologija. 2012;5:34-37. (In Russ.).
  21. Momot AP, Tomilina OP, Molchanova IV, Shipulina VG, Cyvkina LP, Serdjuk GV, et al. Significance of therapeutic correction of hemostasis and fibrinolysis for in vitro fertilization outcomes and early reproductive losses. Reproduktivnaja medicina. 2014;3-4(20):24-26. (In Russ.).
  22. Tranquilli AL. Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens. 2013;3(2):57-61.
  23. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet. 2000;45(3):138-141.
  24. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population based study and systematic review. Thromb Haemost. 2002;87(5):779-785.
  25. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia. Genet Test. 2003;7(3):265-268.
  26. Pegoraro RJ, Hira B, Rom L, Moodley J. Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with preeclampsia. Acta Obstet Gynecol Scand. 2003;82(4):313-317.
  27. Fabbro D, D’Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest. 2003;56(1):17-22.
  28. Tempfer CB, Jirecek S, Riener EK, Zeisler H, Denschlag D, Hefler L, et al. Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig. 2004;11(4):227-231.
  29. De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, et al. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost. 2004;2(9):1588-1593.
  30. Gerhardt A, Goecke TW, Beckmann MW, Wagner KJ, Tutschek B, Willers R, et al. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost. 2005;3(4):686-691.
  31. Dalma´z CA, Santos KG, Botton MR, Tedoldi CL, Roisenberg I. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis. 2006;37(2):107-110.
  32. Muetze S, Eggermann T, Leeners B, Birke C, Kuse S, Ortlepp JR, et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome. J Thromb Thrombolysis. 2007;27(2):141-145.
  33. Kobashi G, Ohta K, Yamada H, Hata A, Minakami H, et al. 4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of vriants of angiotensinogen and endothelial nitric oxide synthase. J Epidemiol. 2009;19:275-280.
  34. Said JM, Tsui R, Borg AJ, Higgins JR, Moses EK, Walker SP, et al. The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women. J Thromb Haemost. 2012;10(5):881-886.
  35. Ivanov P, Komsa-Penkova R, Ivanov I, Bozhinova S, Stoianova A. Carriers of thrombophilic factor among women with preeclampsia (preliminary report). Akush Ginekol (Sofiia). 2007;46(8):3-8.
  36. Kamal M, El-Khayat W. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia? J Investig Med. 2011;59(7):1147-1150.
  37. Kankova K, Benes P, Unzeitig V, Izakovicova-Holla L, Znojil V, Vacha J. Lack of association between pregnancy-induced hypertension and familial thrombophilia in a Czech population. Prenat Neonatal Med. 2000;5(4):223-229.
  38. Larciprete G, Gioia S, Angelucci PA, Brosio F, Barbati G, Angelucci GP, et al. Single inherited thrombophilias and adverse pregnancy outcomes. J Obstet Gynaecol Res. 2007;33(4):423-430.
  39. Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal. Arch Gynecol Obstet. 2006;273(6):322-324.
  40. Morgan JA, Bombell S, McGuire W. Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review. PLoS One. 2013;8(2) *Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574018/ (Accessed 1 April 2016)
  41. Zhao L, Bracken MB, Dewan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and metaanalysis. Mol Hum Reprod. 2013;19(3):136-143.
  42. Buurma AJ, Turner RJ, Driessen JHM, Mooyaart AL, Schoones JW, Bruijn JA, et al. Genetic variants in pre-eclampsia: a metaanalysis. Human Reproduction Update. 2013;(19)3:289-303.
  43. Trifonova EA, Agarkova TA, Gabitova NA, Gabidulina TV, Stepanov VA. Molecular-genetic factor analysis of inherited thrombophilia during gestosis. Sibirskij medicinskij zhurnal. 2010;(25)4-2:34-36. (In Russ.).
  44. Zajnulina AG, Husnutdinova YeK. The fibrinolytic system genes significance in pre-eclampsia development. Molekuljarnaja medicina. 2010;5:47-50. (In Russ.).
  45. Vashukova ES, Glotov AS, Bikmullina DR, Zajnulina MS, Baranov VS. Inherited thrombophilia and risk of pre-eclampsia for Russian pregnant women. Medical genetics. 2010;11:39-45. (In Russ.).
  46. Chajka VK, Mertil BF. State of hemostatic system, a spectrum of thrombophilia genes and afterbirth morphology in parturients of south eastern region of ukraine with moderate and severe preeclampsia. Mediko-social'nye problemy sem'i. 2014;19(1):6-13. (In Russ.).
  47. Shifman EM, Barinov SV, Dolgih TV, Medjannikova IV, Blauman SI. Prevention of obstetric complications associated with thrombophilia gene polymorphisms. Gematologija i transfuziologija. 2015;60(1):24-28. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.